Companies › Altheus Therapeutics

Altheus Therapeutics

Healthcare 📍 Oklahoma City, United States 👥 11-50 employees 💰 $10.1M raised 📅 Founded 2006

Altheus Therapeutics, Inc. is developing Zoenasa® Oral Tablets and Rectal Gel formulations as novel front-line therapies for the treatment of ulcerative colitis and other inflammatory bowel diseases (IBD). Current front-line therapy for ulcerative colitis is the anti-inflammatory mesalamine (5-aminosalicylic acid; 5-AS

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
11-50
Total Raised · Private Equity
$10.1M
Founded
2006
Cloud
Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
Workspace🔒 Subscribers only
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Altheus Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction